JP Stock MarketDetailed Quotes

4582 SymBio Pharmaceuticals

Watchlist
  • 233
  • -6-2.51%
20min DelayMarket Closed Nov 1 15:00 JST
10.70BMarket Cap-4736P/E (Static)

SymBio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SymBio Pharmaceuticals Q3 2024 Earnings Date

Currency：JPYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
613.94M
--
-50.59%
EPS
--
-28.68
--
-60.49%
Analyst Rating
No Data

SymBio Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Nov 11, 20212021/Q32.407B / ----
May 13, 20212021/Q11.420B / ----
Nov 10, 20202020/Q3972.000M / ----
May 12, 20202020/Q1551.000M / ----
Nov 8, 20192019/Q34.000M / ----
DatePeriodRevenue/EstimateEarnings Call
Nov 11, 20212021/Q32.407B / ----
May 13, 20212021/Q11.420B / ----
Nov 10, 20202020/Q3972.000M / ----
May 12, 20202020/Q1551.000M / ----
Nov 8, 20192019/Q34.000M / ----

Unlock Free Earnings Estimates

SymBio Pharmaceuticals Earnings Reports

  • SymBio Pharmaceuticals: Summary of Financial Results for the 3rd Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)

    Oct 31 02:30 ET

  • SymBio Pharmaceuticals: Confirmatory letter.

    Aug 2 02:06 ET

  • SymBio Pharmaceuticals: Semiannual Report - 20th Period (01/01/2024 - 12/31/2024)

    Aug 2 02:05 ET

  • SymBio Pharmaceuticals: Short message of the consolidated financial statements for the second quarter of the fiscal year ending December 2024 [Japan Standards]

    Aug 1 02:30 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data